For juvenile idiopathic arthritis (JIA), 2024 was marked by both successes and heightened controversy. There were new US Food and Drug Administration (FDA) warnings for DRESS (drug reaction with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback